Is Sanofi-Synthelabo (India) Ltd. - (Amalgamated) a good quality company?

Data is not available for this company.

What is Sanofi-Synthelabo (India) Ltd. - (Amalgamated) share price return in the past 10 years?

Data is not available for this company

What is the share price of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Sanofi-Synthelabo (India) . - (Amalgamated)?

The latest standalone P/E ratio of Sanofi-Synthelabo (India) . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

The latest standalone P/B ratio of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

The 52-week high of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) is Rs. and the 52-week low is Rs. .

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Sanofi-Synthelabo (India) Ltd. - (Amalgamated)
Brand: Sanofi-Synthelabo (India) . - (Amalgamated)

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

BSE: 0 NSE:

Key Metrics

Market Cap

₹0 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Return on Capital Employed (ROCE)

15.61%

Current Price

₹0

Return on Equity (ROE)

8.56%

Return on Assets (ROA)

4.94%

Operating Profit Margin

11.3%

Net Profit Margin

6.94%

Gross Profit Margin

14.6%

Book Value per Share

₹0

Sales Growth (YoY)

10.85%

Sales Growth (3 Years)

12.37%

Operating Profit Growth (1 Year)

-15.1%

Operating Profit Growth (3 Years)

129.26%

Net Profit Growth (1 Year)

-23.8%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

107.44%

Dividend Yield

0.00%

Promoter Holding

Pledged shares (%)
of Promoter's holding (%)

DeciZen - make an informed investing decision on Sanofi-Synthelabo (India) Ltd.

Based on:

Data

M-Cap below 100cr DeciZen not available

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) stock performance

Key Ratios

Is an attractive stock to invest in?

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	47.1%	48.5%	46%	43.5%	2.8%	-12.8%	2.8%	46.4%	19.5%	15.6%	-
Value Creation Index ⓘ	2.4	2.5	2.3	2.1	-0.8	-1.9	-0.8	2.3	0.4	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	186	216	243	327	355	409	428	536	547	607	607
Sales YoY Gr.	-	16.1%	12.5%	34.3%	8.8%	15%	4.6%	25.3%	2.2%	10.9%	-
Adj EPS ⓘ	10	13.3	17.5	22.6	1.6	-3.6	1.1	6.2	15	13	0
YoY Gr.	-	34.1%	31.5%	29%	-92.8%	-322.1%	NA	484%	142.7%	-13.6%	-
BVPS (₹) ⓘ	34.8	48.3	66	88.8	90.4	92.8	94.2	126	142.2	154.7	0
Adj Net Profit ⓘ	27.9	37.4	49.1	63.4	4.6	-12	3.5	20.5	49.8	43	0
Cash Flow from Ops. ⓘ	26.1	44.1	51.7	53.1	20.7	68.4	64.5	152	42	64.7	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14%	11.3%	12.4%	10.9%
Adj EPS ⓘ	3%	51.4%	130.5%	-13.6%
BVPSⓘ	18%	11.3%	18%	8.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	33.3	32.1	30.7	29.2	1.8	-4.3	1.1	5.6	11.1	8.6	0
Op. Profit Mgn % ⓘ	26.1	27.5	29.2	26.3	10.1	16.5	1.3	8.2	14.5	11.3	NAN
Net Profit Mgn % ⓘ	15	17.3	20.2	19.4	1.3	-2.9	0.8	3.8	9.1	7.1	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	83	81	142	119	98	104	100	86	170	245	0
Cash Conv. Cycle ⓘ	18	-6	-7	-16	19	30	-5	-7	25	17	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	607	-
BVPS (₹) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	480	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Sanofi-Synthelabo (India) Ltd. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	186.16	216.18	243.11	326.57	355.44	408.87	427.57	535.67	547.25	606.64
Operating Expenses ⓘ +	138.43	156.82	172.10	240.65	319.42	375.16	421.99	491.53	468.05	539.40
Manufacturing Costs	61.78	6.42	6.14	11.75	12.69	30.50	36.93	39.43	96.32	90.12
Material Costs	50.08	56.62	62.75	70.70	108.15	118.36	87.64	93.06	162.75	205.09
Employee Cost	7.11	8.79	14.30	29.65	43.78	47.56	47.15	56.09	64.35	70.61
Other Costs ⓘ	19.46	84.99	88.91	128.55	154.80	178.74	250.27	302.95	144.63	173.58
Operating Profit ⓘ	47.74	59.36	71.01	85.92	36.02	33.71	5.58	44.14	79.20	67.24
Operating Profit Margin (%)	25.6%	27.5%	29.2%	26.3%	10.1%	8.2%	1.3%	8.2%	14.5%	11.1%
Other Income ⓘ +	0.83	3.54	9.14	14.83	4.72	5.14	10.07	11.62	21.10	21.57
Exceptional Items ⓘ	0	0	0	0	0	0	0	122.97	5.77	0
Interest ⓘ	0.17	0	0.03	0	0.01	0	0	0	0	0.46
Depreciation ⓘ	6.28	6.47	6.51	6.50	33.79	74.77	6.98	8.93	19.04	11.03
Profit Before Tax ⓘ	42.11	56.43	73.61	94.25	6.94	-35.92	8.67	169.80	87.03	77.32
Tax ⓘ	14.53	18.86	23.85	30.45	2.36	-0.21	3.95	63.22	31.74	35.19
Profit After Tax	27.57	37.57	49.76	63.80	4.58	-35.71	4.72	106.58	55.29	42.13
PAT Margin (%)	14.8%	17.4%	20.5%	19.5%	1.3%	-8.7%	1.1%	19.9%	10.1%	6.9%
Adjusted EPS (₹)	9.9	13.4	17.8	22.8	1.6	-10.8	1.4	32.2	16.7	12.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	97.52	135.09	184.85	248.65	253.23	307.52	312.24	417.67	471.20	512.76
Share Capital ⓘ	28	28	28	28	28	33.14	33.14	33.14	33.14	33.14
Reserves ⓘ	69.52	107.09	156.85	220.65	225.23	274.38	279.10	384.53	438.06	479.62
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	19.32	18.14	19.69	37.09	39.39	44.92	49.94	48.06	72.23	96.84
Others Liabilities ⓘ	5.18	9.45	12.98	16.02	28.65	19.84	12.39	45.32	256.07	295.42
Total Liabilities ⓘ	122.02	162.68	217.52	301.76	321.27	372.28	374.57	511.05	799.50	905.02
Fixed Assets
Net Fixed Assets ⓘ +	56.13	50.54	46.89	42.61	176.77	103.98	33.46	82.94	78.93	74.20
Gross Block	110.57	111.01	113.78	115.76	283.45	285.01	288.61	91.87	106.90	112.81
Accumulated Depreciation	54.43	60.47	66.89	73.15	106.68	181.03	255.15	8.93	27.97	38.61
CWIP ⓘ	0.06	0.04	0	0	0.39	0.82	0.50	8.56	1.27	1.90
Investments ⓘ	0	0	0	0	0	56.21	56.21	26.57	26.57	0
Inventories	28.34	26.50	25.96	32.82	56.08	48.83	51.83	69.69	58.86	71.53
Trade Receivables	11.74	14.12	17.12	26.26	44.56	46.92	47.98	41.24	82.04	73.95
Cash Equivalents ⓘ	18.15	61.88	28.41	184.72	24.50	94.75	162.77	259.18	314.21	392.17
Others Assets ⓘ	7.59	9.60	99.14	15.35	18.97	20.77	21.82	22.87	237.62	291.27
Total Assets ⓘ	122.02	162.68	217.52	301.76	321.27	372.28	374.57	511.05	799.50	905.02

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	26.09	44.10	51.74	53.05	20.71	68.41	64.50	151.56	42.03	64.70
PBT ⓘ	42.11	56.43	73.61	94.25	6.94	-35.92	91.56	184.36	87.03	77.32
Adjustment ⓘ	6.03	3.77	-1.38	-6.53	30.40	104.94	-16.21	-15.36	26.74	28.05
Changes in Working Capital ⓘ	-7.38	1.08	3.02	-2.61	-7.28	11.63	6.5	-8.46	-34.19	2.51
Tax Paid ⓘ	-14.67	-17.18	-23.54	-32.06	-9.35	-12.24	-17.35	-38.62	-37.55	-43.18
Cash Flow From Investing Activity ⓘ +	-0.96	-0.37	-85.18	103.26	-180.92	-88.16	3.52	-55.15	12.52	13.26
Capex	-1.16	-0.85	-2.82	-2.28	-11.21	-2.23	-4.21	-66.44	-7.94	-8.08
Net Investments	0	0	0	0	0	-90	0	0	0	0
Others ⓘ	0.20	0.48	-82.36	105.54	-169.71	4.07	7.73	11.29	20.46	21.34
Cash Flow From Financing Activity ⓘ +	-12.17	0	-0.03	0	-0.01	90	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-12	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.17	0	-0.03	0	-0.01	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	90	0	0	0	0
Net Cash Flow ⓘ	12.95	43.73	-33.47	156.31	-160.22	70.25	68.02	96.41	54.55	77.96

Finance Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	32.93	32.3	31.11	29.43	1.83	-12.74	1.52	29.2	12.44	8.56
ROCE (%)	47.12	48.52	46.03	43.48	2.77	-12.81	2.8	46.44	19.45	15.61
Asset Turnover Ratio	1.67	1.54	1.3	1.28	1.16	1.2	1.17	1.23	0.84	0.71
PAT to CFO Conversion(x)	0.95	1.17	1.04	0.83	4.52	N/A	13.67	1.42	0.76	1.54
Working Capital Days
Receivable Days	24	22	23	24	36	40	40	30	41	47
Inventory Days	46	46	39	32	45	46	42	41	43	39
Payable Days	145	121	110	147	129	130	198	192	135	150

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) FAQs

The current trading price of Sanofi-Synthelabo (India) Ltd. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sanofi-Synthelabo (India) Ltd. stood at ₹0.00 Cr

The latest P/E ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.

The 52-week high of Sanofi-Synthelabo (India) Ltd. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi-Synthelabo (India) Ltd. is ₹607 ( Cr.) .

About Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating